Pharmacokinetics of recombinant human interleukin-2 in advanced renal cell carcinoma patients following subcutaneous application

AIMS: The aim of the study was to investigate the pharmacokinetics of recombinant human interleukin-2 (rhIL-2) in patients with metastatic renal cell carcinoma following different subcutaneous (s.c.) administration regimens. METHODS: RhIL-2 was administered subcutaneously to 10 patients according to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kirchner, G I, Franzke, A, Buer, J, Beil, W, Probst-Kepper, M, Wittke, F, Övermann, K, Lassmann, S, Hoffmann, R, Kirchner, H, Ganser, A, Atzpodien, J
Format: Artigo
Sprache:Inglês
Veröffentlicht: Blackwell Science Inc 1998
Schlagworte:
Original Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC1873983/
https://ncbi.nlm.nih.gov/pubmed/9690943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2125.1998.00036.x
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge